- Molekulární cíle nových léčiv2016 | 1. lékařská fakulta
- 1-(Benzo[d]thiazol-2-yl)-3-phenylureas as dual inhibitors of casein kinase 1 and ABAD enzymes for treatment of neurodegenerative disorders2018 | 1. lékařská fakulta
- Progress in drug development for Alzheimer's disease: An overview in relation to mitochondria energy metabolism2016 | 1. lékařská fakulta
- 6-Benzothiazolyl ureas, thioureas and guanidines are potent inhibitors of ABAD/17 beta-HSD10 and potential drugs for Alzheimer's disease treatment: Design, synthesis and in vitro evaluation2017 | Publikace bez příslušnosti k fakultě
- Newly developed drugs for Alzheimer's disease in relation to energy metabolism, cholinergic and monoaminergic neurotransmission2018 | 1. lékařská fakulta